IP Litigation: Fran Morrison Comments on Qualcomm Legal Issues in Wall Street Journal and The Recorder
September 10, 2007
Fran Morrison spoke with Don Clark, investigative journalist for the Wall Street Journal about Qualcomm's continuing legal problems- in particular, a cache of non-disclosed evidence in the form of 21 emails. "This is every trial lawyer's nightmare," says Francis H. Morrison, III, a lawyer for Axinn who isn't involved in the case." The article, "Recovered Emails Bedevil Qualcommin Court," was featured in the Marketplace section in the October 9th issue. The Qualcomm legal battle with Broadcom provided The Recorder with an opportunity to speak with Fran about the world of big IP fees. "'The rate disparity between the top attorneys at the two firms may be an indication of how different those legal markets are', said Francis Morrison III, an IP litigator with Axinn in Connecticut. Morrison wasn't surprised by the fees, but said many outside the legal profession would find it steep. 'A human being getting $800 an hour for something is a lot," he said. 'Lawyers do wonderful things for clients. But we're not doing neurosurgery at the nearest hospital.'"
The article, "Dispute Between Broadcom and Qualcomm Provides Window Into World of Big IP Fees," is in the September 10th issue.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
SABA North America Annual Conference 2025
Speaking Engagement
Antitrust
Navigating Compliance: How the 2025 Hart-Scott-Rodino Updates Are Impacting Businesses
Webinar
Antitrust
NJSBA Annual Meeting and Convention 2025
Speaking Engagement
Intellectual Property
Hartford HealthCare Black and Red Gala 2025
Sponsorship
Antitrust
Informa CompLaw Antitrust West Coast Conference 2025
Speaking Engagement
Antitrust
AHLA Health Care Transactions Program 2025
Sponsorship
Antitrust
IAM Live: Auto IP USA 2025
Speaking Engagement
Intellectual Property
ACI 21st Annual Paragraph IV Conference
Speaking Engagement
Intellectual Property
A Check-in on the Structural Presumption: What Have We Learned and Where Are We Headed?
Webinar
Antitrust
Biosimilars Litigation and Client Counseling
Byline Articles